National Heart, Lung and Blood Institute (NHLBI) is a clinical research site located in Bethesda, Maryland, United States 20892.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
National Heart, Lung and Blood Institute (NHLBI) has participated in 98 clinical trials with 1 currently active.
Therapeutic areas: Abetalipoproteinemia, Lung Transplantation, Atherosclerosis.
Sponsors: National Heart, Lung, and Blood Institute (NHLBI).
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
National Heart, Lung and Blood Institute (NHLBI) has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
National Heart, Lung and Blood Institute (NHLBI) has 98 clinical trials on record, with 1 currently active. Their work covers Abetalipoproteinemia, Lung Transplantation, Atherosclerosis.
Yes — National Heart, Lung and Blood Institute (NHLBI) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.